Angstgestörungen    Bipolare Störung    Demenz    Depression    Epilepsie    Migräne    Morbus Parkinson    Multiple Sklerose    Panikstörung  
  Schizophrenie    Schlafstörungen    Schlaganfall  
 

Weitere Abbildungen des Gehirns
    Prosencephalon
    Mesencephalon
    Metencephalon
    Rückenmark
    Hirnlappen
    Limbisches System
    Koronarschnitt
    Gehirngefäße

 

Morbus Parkinson

Literatur

Adams RD, Victor M, Ropper AH. Principles of Neurology. (6. Aufl.). München: McGraw-Hill; 1997. S. 1067–1078.

Clarke CE. Parkinson's Disease in Practice. London: Royal Society of Medicine Press Ltd, 2001.

Defer GL, Widner H, Marie RM, et al. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Movement Disorders 1999; 14:572–584.

Fahn S. Parkinsonism. In: Merritt's Textbook of Neurology Rowland LP (eds.). (9. Aufl.). Baltimore: William & Wilkins; 1995. S. 713–730.

Gasser T. Genetics of Parkinson's disease. Ann Neurol 1998; 44:S53–S57.

Gelb DJ, Oliver E, Gilman S. Diagnostic Criteria for Parkinson disease. Arch Neurol 1999; 56:33–39.

Gibb WRG, Lees AJ. Pathological clues to the cause of Parkinson's disease. In: Movement Disorders 3. Marsden CD, Fahn S (eds.). Oxford, UK: Butterworth-Heinemann; 1994. S. 147–165.

Goetz CG, Jankovic J, Koller WC, et al. Preclinical disease. differential diagnosis. Continuum 1995; 1:26–61.

Goetz CG, Koller WC, Poewe W, et al. Management of Parkinson's disease: An evidence-based review. Mov Disord 2002; 17:S1–S166.

Gomez AG, Jorge R, Garcia S, et al. Clinical and pharmacological differences in early- versus late-onset Parkinson's disease. Mov Disord 1997; 12:277–284.

Hely MA, Morris JG, Reid WG, et al. Age at Onset: the major determinant of outcome in Parkinson's disease. Acta Neurol Scand 1995; 92:455–463.

Hughes AJ, Daniel SE, Ben-Shlomo Y, et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002; 125:861–870.

Hughes AJ, Daniel SE, Kilford L et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55:181–184.

Jankovic J, McDermott M, Carter l, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. Neurology 1990; 40:1529–1534.

Koller WC, Hutton JT, Tolosa E, et al. Immediate-release and controlled-release carbidopa/levodopa in PD: a 5-year randomized multicenter study. Neurology 1999; 53:1012–1019.

Korczyn AD, Brunt ER, Larsen JP, et al. A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease. Neurology 1999; 53:364–370.

Langston JW, Widner H, Goetz CG, Brooks, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992; 7:2–13.

Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome). Neurology 1996; 46:922–930.

Litvan I, Bhatia KP, Burn DJ, et al. SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003; 18:467–486.

Litvan I, MacIntyre A, Goetz CG, et al. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 1998; 55:969–978.

Piccini P, Burn DJ, Ceravolo R, et al. The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 1999; 45:577–582.

National Parkinson’s Foundation. What Are Your Chances of Getting Parkinson Disease? 2002.

Poewe WH, Wenning GK. The natural history of Parkinson's disease. Neurology 1996; 47:S146–S152.

Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in Parkinsonism: a prospective study. Can J Neurol Sci 1991; 18:275–278.

Schrag A, Ben-Shlotno Y, Brown R, et al. Young-onset Parkinson's disease revisited – clinical features, natural history, and mortality. Mov Disord 1998; 13:885–894.

The Deep Brain Stimulation for Parkinson’s Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med 2001; 345:956–963.

The Parkinson Disease Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1989; 321:1364–1371.

Volkman J, Allert N, Voges J, et al. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 2002; 56:548–551.

Ward C und Gibb W. Research diagnostic criteria for Parkinson’s disease. In: Advances in neurology: Parkinson’s disease: Anatomy, Pathology, and Therapy. Streifler M, Korczyn A, Melamed E, Youdim M (eds.). München: Raven Press; 1990.

 

 

 

 

   Feedback       Sitemap        Hilfe        Home        Wissenschaftlicher Beirat